Tenaya Therapeutics, Inc.
TNYA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$111,129 | -$124,084 | -$123,665 | -$72,721 |
| Dep. & Amort. | $8,468 | $8,687 | $6,467 | $2,961 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $16,501 | $15,309 | $11,467 | $2,950 |
| Change in WC | -$7,931 | -$5,648 | -$849 | $4,742 |
| Other Non-Cash | $3,590 | $3,664 | $2,156 | $1,256 |
| Operating Cash Flow | -$90,501 | -$102,072 | -$104,424 | -$60,812 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,025 | -$1,239 | -$20,630 | -$25,121 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$87,069 | -$56,644 | -$140,476 | -$213,443 |
| Inv. Sales/Matur. | $89,208 | $106,623 | $244,750 | $0 |
| Other Inv. Act. | $17 | -$25 | $8 | $0 |
| Investing Cash Flow | $1,131 | $48,715 | $83,652 | -$238,564 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $46,762 | $3,868 | $77,387 | $188,541 |
| Stock Repurch. | $0 | $0 | $0 | -$13 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $987 | $181 | $380 | $20,442 |
| Financing Cash Flow | $47,749 | $4,049 | $77,767 | $208,970 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$41,621 | -$49,308 | $56,995 | -$90,406 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $46,363 | $95,671 | $38,676 | $129,082 |
| End Cash | $4,742 | $46,363 | $95,671 | $38,676 |
| Free Cash Flow | -$91,526 | -$103,311 | -$125,054 | -$85,933 |